Location History:
- East Lyme, CT (US) (1976 - 1980)
- Bend, OR (US) (2023)
Company Filing History:
Years Active: 1976-2023
Title: Innovations of Jacob J. Plattner: A Pioneer in Pharmaceutical Inventions
Introduction
Jacob J. Plattner is a notable inventor based in East Lyme, Connecticut, whose contributions to the field of pharmaceuticals have resulted in numerous patents. With a total of ten patents to his credit, Plattner has made significant strides in developing new compounds that address various medical conditions. His innovative research focuses on the enhancement of drug efficacy and the discovery of novel therapeutic agents.
Latest Patents
Among his latest patents, Plattner has developed several groundbreaking compounds. One of his notable inventions is the "Substituted 1,2-oxaborolan-2-ols as PDE4 inhibitors." This invention pertains to boron-containing compounds capable of inhibiting phosphodiesterase 4 (PDE4), which plays a critical role in several biological processes. The patent also includes pharmaceutical compositions containing these compounds and outlines methods for treating diseases or disorders that can benefit from PDE4 inhibition.
Another significant patent is for "4-Pyrone prostaglandin antagonists," which describes novel 2,3,6-substituted-4-pyrones with activity as prostaglandin antagonists. This innovation includes intermediates useful for the preparation of these compounds, as well as methods for utilizing them as prostaglandin antagonists.
Career Highlights
Plattner has notably contributed to the pharmaceutical landscape through his work at Pfizer Corporation, one of the leading global biopharmaceutical companies. His efforts in research and development have positioned him as a distinguished figure in the industry, allowing him to advance medical science through innovative drug discovery.
Collaborations
Throughout his career, Jacob J. Plattner has collaborated with a number of esteemed colleagues, including Donald E. Kuhla and Michael Ross Johnson. These collaborations have fostered a creative environment that encourages the sharing of ideas and the advancement of scientific knowledge, ultimately enhancing the potential for novel medicinal breakthroughs.
Conclusion
In summary, Jacob J. Plattner stands out as a prominent inventor in the pharmaceutical domain. With his innovative patents and impactful collaborations, Plattner continues to push the boundaries of what's possible in drug development. His work not only reflects his dedication to scientific advancement but also holds the promise of improving patient outcomes through novel therapeutic solutions.